share_log

4: Statement of changes in beneficial ownership of securities-Officer Kupiec James William

4: Statement of changes in beneficial ownership of securities-Officer Kupiec James William

4：持股变动声明-高管 Kupiec James William
美股sec公告 ·  04/22 09:20
Moomoo AI 已提取核心信息
James William Kupiec, the Chief Medical Officer of Cassava Sciences, completed a purchase of 1,500 shares of common stock on April 18, 2024. The transaction was carried out at a price of $22.00 per share, resulting in a total investment of $33,000. Following this acquisition, Kupiec's direct holdings in the company increased to 4,000 shares. The transaction is reported as an exercise or conversion of derivative security, indicating a potential increase in the executive's confidence in the company's future.
James William Kupiec, the Chief Medical Officer of Cassava Sciences, completed a purchase of 1,500 shares of common stock on April 18, 2024. The transaction was carried out at a price of $22.00 per share, resulting in a total investment of $33,000. Following this acquisition, Kupiec's direct holdings in the company increased to 4,000 shares. The transaction is reported as an exercise or conversion of derivative security, indicating a potential increase in the executive's confidence in the company's future.
木薯科学首席医学官詹姆斯·威廉·库皮克于2024年4月18日完成了对1,500股普通股的购买。该交易以每股22.00美元的价格进行，总投资为33,000美元。此次收购后，库皮克在该公司的直接持股量增加到4,000股。该交易被报告为衍生证券的行使或转换，这表明高管对公司未来的信心可能会增强。
木薯科学首席医学官詹姆斯·威廉·库皮克于2024年4月18日完成了对1,500股普通股的购买。该交易以每股22.00美元的价格进行，总投资为33,000美元。此次收购后，库皮克在该公司的直接持股量增加到4,000股。该交易被报告为衍生证券的行使或转换，这表明高管对公司未来的信心可能会增强。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息